Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.38 |
| ▸ | MME | P08473 | 2/20 | 0.38 |
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.38 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | ECE1 | P42892 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.31 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.31 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25011832 | 0.87 | NAALAD2 (0.40) | GABRR1MMENAALAD2FOLH1ACE | |
| SCHEMBL25811807 | 0.84 | GABRR1 (0.39) | GABRR1MMENAALAD2FOLH1ACE | |
| SCHEMBL24753917 | 0.84 | GABRR1 (0.39) | GABRR1MMENAALAD2FOLH1ACE | |
| SCHEMBL24141307 | 0.84 | GABRR1 (0.39) | GABRR1MMENAALAD2FOLH1ACE | |
| SCHEMBL19302558 | 0.84 | GABRR1 (0.39) | GABRR1MMENAALAD2FOLH1ACE | |
| SCHEMBL26852933 | 0.82 | MME (0.36) | MMEACEECE1 | |
| SCHEMBL26852942 | 0.82 | MME (0.36) | MMEACEECE1 | |
| SCHEMBL25633002 | 0.81 | MME (0.63) | MMEACECACNA2D1CACNB3CACNA1C | |
| SCHEMBL23346343 | 0.76 | CACNA2D1 (0.38) | GABRR1MMEACEECE1CACNA2D1 | |
| SCHEMBL24141313 | 0.76 | CACNA2D1 (0.38) | GABRR1MMEACEECE1CACNA2D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210402002-A1 | CONJUGATE | GLYKOS BIOMEDICAL OY (FI) | 2021-12-30 | — | — | US | disclosed |
| US-20210138080-A1 | CONJUGATES | GLYKOS BIOMEDICAL OY (FI) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210402002-A1 | CONJUGATE | ST6GAL1, CSGALNACT1, FUT6 | GABRR1 2050/4885MME 560/4885NAALAD2 130/4885 |
| US-20210138080-A1 | CONJUGATES | LGALS1, LGALS3BP, LGALS2 | GABRR1 3335/4885MME 447/4885NAALAD2 81/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.